Medtronic plc said Wednesday it will purchase Medicrea Group, a French manufacturer of patient-specific 3D printed spinal implants, in a step to further strengthen its spine surgery business. The friendly, all-cash offer is priced at €7 (US$7.98) for each Medicrea share, a 22% over its July 14 closing price. The total value of the deal is approximately €200 million (about US$228 million), which includes roughly €50 million in net cash and liabilities plus about €150 million in equity. Medtronic expects to close the deal by the end of the year, pending regulatory nods in France and the U.S. Read More
Glympse Bio has closed an oversubscribed $46.7 million series B financing, with an eye toward boosting its novel biosensor platform in fibrotic diseases, including nonalcoholic steatohepatitis (NASH), oncology and infectious diseases. Read More
The case of Fitbit Inc. v. Valencell Inc. has seen the usual number of twists and turns as it wended its way through Article III courts and an inter partes review (IPR), but a U.S. Supreme Court case that requires that all claims in an IPR be reviewed was decided during the Fitbit IPR. Read More
Novocure Ltd. and Merck & Co. Inc. will work together to test the use of electric fields at specific frequencies in combination with anti-PD-1 immunotherapy Keytruda (pembrolizumab) to treat non-small-cell lung cancer (NSCLC). The pair plan to start a phase II pilot study during the second half of Novocure’s Tumor Treating Fields in combination with Keytruda as a first-line treatment for intrathoracic advanced or metastatic, PD-L1 positive NSCLC. Read More
At about $35.6 billion raised by med-tech companies, the first half of 2020 has already pulled in more than the full-year totals for 2017 and 2018 and is at about 87% of what was raised in 2019. Most of the money is coming through private financings of public companies, including large notes offerings and private placements, as well as follow-on offerings. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clinical Computer Systems, Diacarta, Edwards, Huntleigh Healthcare, Icad, Paragon 28. Read More
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Becton Dickinson, Merit Medical, Quidel. Read More
Keeping you up to date on recent developments in orthopedics, including: Primitive stem cells point to new bone grafts for stubborn-to-heal fractures; Orthopedic surgeons issue guidelines on resuming elective surgery amid COVID-19 pandemic; Cardiac CT can double as osteoporosis test; Novel bone imaging approach provides insights into the progression of knee osteoarthritis.
